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Validation of monoclonal antibody F99/97.6.1 for
immunohistochemical staining of brain and tonsil in mule deer
(Odocoileus hemionus) with chronic wasting disease
T. R. Spraker, K. I. O’Rourke, A. Balachandran, R. R. Zink, B. A. Cummings, M. W. Miller,
B. E. Powers
Abstract. A new monoclonal antibody (MAb), F99/97.6.1, that has been used to demonstrate scrapie-
associated prion protein PrPSc in brain and lymphoid tissues of domestic sheep with scrapie was used in an
immunohistochemistry assay for diagnosis of chronic wasting disease (CWD) in mule deer (Odocoileus hem-
ionus). The MAb F99/97.6.1 immunohistochemistry assay was evaluated in brain and tonsil tissue from 100
mule deer that had spongiform encephalopathy compatible with CWD and from 1,050 mule deer outside the
CWD-endemic area. This MAb demonstrated abnormal protease-resistant prion protein (PrPres) in brains of all
of the 100 mule deer and in 99 of the 100 tonsil samples. No immunostaining was seen in samples collected
from deer outside the endemic area. MAb F99/97.6.1 demonstrated excellent properties for detection of PrPres
in fresh, frozen, or mildly to moderately autolytic samples of brain and tonsil. This immunohistochemistry
assay is a sensitive, specific, readily standardized diagnostic test for CWD in deer.
Chronic wasting disease (CWD) is one of several
transmissible spongiform encephalopathies affecting
animals and is the only one found in free-ranging mule
deer (Odocoileus hemionus), white-tailed deer (O. vir-
ginianus), and Rocky Mountain elk (Cervus elaphus
nelsoni).14 CWD is most reliably diagnosed in fresh
fixed sections of brain stem, especially the dorsal mo-
tor nucleus of the vagus nerve (DMNV), where spon-
giform encephalopathy is found. However, fresh brain
specimens are usually not available, especially in field
surveys of cervids for CWD. Several slightly different
immunohistochemistry (IHC) techniques have been
developed for detection of protease-resistant prion pro-
tein (PrPres) in elk and deer.2,3,10–14,16 Positive IHC re-
sults have been interpreted as evidence that a scrapie-
associated prion protein or an antigenically similar
PrPres is present in lymphoid tissues and brain of cap-
tive and free-ranging deer and elk.2,3,10–14 Therefore,
detection of PrPres in tissues would help to confirm
CWD in questionable cases. The objective of this in-
vestigation was to evaluate the utility of monoclonal
antibody (MAb)-based IHC assay for detection of
PrPres in mule deer with CWD. This assay can be used
in antemortem testing of experimentally inoculated an-
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imals in the preclinical stages of the disease and in
antemortem and postmortem sampling of free-ranging
animals to estimate CWD prevalence.
Materials and methods
This study included 100 mule deer that had a spongiform
encephalopathy of the brain histologically compatible with
CWD. Sections of palatine tonsil and multiple sections of
brain, with 1 section always from the medulla at the level
of the obex and including the DMNV, were preserved in
10% neutral buffered formalin and embedded in paraffin.
Duplicate sections were cut at 5 m and mounted on posi-
tively charged glass slides. One slide was stained with he-
matoxylin and eosin (HE),7 and the other was assayed by
MAb F99/97.6.1 IHC (MAb99-IHC). MAb F99/97.6.1a re-
acts with a conserved epitope (residues QYQRES) on the
prion protein of mule deer, Rocky Mountain elk, domestic
sheep, and cattle.10 MAbs specific for scrapie-associated
prion protein PrPSc in formalin-fixed tissues have not been
described. Formalin fixation and formic acid treament-AP.1
reduces or eliminates the availability of the epitope for MAb
F99/97.6.1 in cervid brain and lymphoid tissues. Antigen
retrieval with formic acid6 and hydrated autoclaving5 selec-
tively unmasks the epitope on PrPSc in fixed tissues.
The CWD-positive mule deer in this study had been di-
agnosed by examination of HE-stained slides with confir-
mation by IHC of brain tissues using MAb F89/160.1.5.11
The epitope for MAb F89/160.1.5 (residues IHFG) on sialo-
glycoprotein (PrPsen) is eliminated by formalin fixation and
formic acid treatment in cervid brain, as evidenced by the
failure to detect immunostaining in brain samples from more
than 1,000 deer harvested outside the CWD-endemic area.
Preliminary trials of antigen retrieval conditions for lym-
phoid tissue demonstated that the intensity of immunostain-
ing was higher when a modified citrate acid bufferb was used
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Figure 1. Obex, brain (low power) from a mule deer that does not have chronic wasting disease. Note the absence of any red chromogen
staining. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar  650 m.
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Figure 2. Obex, brain (high power) from a mule deer that does not have chronic wasting disease. Note the absence of any red chromogen
staining. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar  30 m.
Figure 3. Obex, brain (low power) from a mule deer with chronic wasting disease. Note the abundant red chromogen filling the dorsal
motor nuclei of the vagus (V) and the lack of staining in the hypoglossal nuclei (H). Immunohistochemical staining. Streptavidin–alkaline
phosphatase method. Hematoxylin/bluing counterstain. Bar  650 m.
Figure 4. Obex, brain (high power) from a mule deer with chronic wasting disease. Note the abundant red chromogen associated with
neurons and in the adjacent neuropil of the dorsal motor nuclei of the vagus. Immunohistochemical staining. Streptavidin–alkaline phos-
phatase method. Hematoxylin/bluing counterstain. Bar  70 m.
Figure 5. Thalamus, brain from a mule deer with chronic wasting disease. Note the red chromogen in the neuropil and the plaques of
PrPres. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar  30 m.
Figure 6. Olfactory cortex, brain from a mule deer with chronic wasting disease. Note the distinct area of abundant red chromogen in
the olfactory cortex. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar 
330 m.
Figure 7. Palatine tonsil lymphoid follicles from a mule deer that does not have chronic wasting disease. Note the lack of red chromogen
deposition in the lymphoid follicle. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing coun-
terstain. Bar  240 m.
Figure 8. Palatine tonsil lymphoid follicles from a mule deer with chronic wasting disease. Note the abundant red chromogen deposition
in the lymphoid follicle. Immunohistochemical staining. Streptavidin–alkaline phosphatase method. Hematoxylin/bluing counterstain. Bar
 240 m.
in the hydrated autoclaving step. However, approximately 3–
5% of tonsil samples collected from mule deer outside the
CWD-endemic area showed variable patterns of immuno-
staining with MAb F89/160.1.5 after citrate buffer hydrated
autoclaving. This immunostaining probably represents de-
tection of the normal cellular PrPsen by MAb F89/160.1.5 in
some cervid lymphoid tissues prepared by this method. This
staining was not detectable using MAb F99/97.6.1 under
these staining conditions. Therefore, only MAb F99/97.6.1
was used in the larger study.
Samples of mule deer brain and tonsil were mounted on
the same slide. Brain samples were stained with HE, and
replicate slides were immunostained with MAb99-IHC as
follows. Slides were dried in a 65 C oven overnight, depar-
affinized, rehydrated, and immersed in 88% formic acid for
30 min. The slides were then rinsed in deionized water to
remove residual formic acid. The slides were next auto-
claved in a citrate buffer (pH 6.1)b for 20 min at 121 C,
cooled to room temperature, rinsed with deionized water, and
placed in a Tris buffer.c MAb99-IHC was performed with a
NexES automated immunostainerc at 37 C using an alkaline
phosphatase red kit.c Primary MAb F99/97.6.1 was diluted
to an IgG concentration of 10 g/ml in diluentc and placed
in the refillable dispenser provided with the immunostainer.
The primary antibody, MAb F99/97.6.1, was applied to the
slides for 32 min. Slides were counterstained on the immu-
nostainer with hematoxylinc for 4 min and with bluingc for
another 4 min.
Criteria used for histologic diagnosis of CWD in HE-
stained tissues included intraneuronal vacuolation, microcav-
itation of gray matter, neuronal degeneration and loss, and
mild astrocytosis in the brain stem.14,16–18 Criteria for IHC
diagnosis of CWD on MAb99-IHC–treated slides included
detection of granular red chromogen deposits in brain or
tonsil. The palatine tonsil was considered positive in mule
deer if any follicle contained cells with positive MAb99-IHC
staining. Negative palatine tonsils had no staining in cells of
lymphoid follicles. A typical section of tonsil contained ap-
proximately 100–200 follicles.
Negative controls for this study included brain and tonsil
from 300 mule deer collected from areas within Colorado
but outside of the areas endemic for CWD.9 In these mule
deer, a single section of obex and tonsil were stained with
HE and MAb99-IHC. Free-ranging mule deer (n  750) col-
lected from Montana, where CWD has not been found in
the wild, were also used as negative controls.
Results
Spongiform encephalopathy and PrPres was not ob-
served in the brain stem of any of the negative control
mule deer examined in this study (Figs. 1, 2).
PrPres was demonstrated by MAb99-IHC in the brain
sections of all of the mule deer that had spongiform
encephalopathy. PrPres in brain was characterized by
coarse granular staining by the red chromogen. The
staining was located on the periphery around neurons
and in the neuropil, often in plaques adjacent to or near
glial cells (Figs. 3, 4). There were also plaques with
red chromogen stain randomly scattered throughout
the neuropil, especially in the thalamus (Fig. 5). An
abundance of PrPres was found in the olfactory cortex
(Fig. 6).
Ninety-nine of the 100 mule deer had extensive
staining within follicles of the palatine tonsil. Staining
in the tonsils was in the germinal centers of the lym-
phoid follicles, but the PrPSc-positive cell type cannot
be distinguished microscopically because of the exten-
sive cytoplasmic processes of the follicular dendritic
cells interdigitating with lymphocytes and macrophag-
es. One deer with extensive spongiform encephalopa-
thy and positive MAb99-IHC staining in the brain did
not have any tonsillar staining in lymphoid follicles.
The tonsil and brain of this mule deer were also im-
munostained with MAb F89/160.5.1, and this assay
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also demonstrated strong staining in the brain but not
in the lymphoid follicles of the tonsil.
A negative palatine tonsil had no staining in lym-
phoid follicles (Fig. 7). PrPres in the palatine tonsil was
characterized by a coarse granular, bright red material
in lymphoid follicles (Fig. 8). In a typical positive pal-
atine tonsil section, 50% of the follicles were filled
with bright red chromogen.
Freeze artifacts in brain and tonsil varied from mi-
nor to marked tissue clefting. Autolysis varied from
mild clear spaces around neurons, lymphoid cells, and
vasculature to tissue architecture disruption with clear
spaces and loss of staining with hematoxylin. Regard-
less of the degree of freeze artifact or autolysis, im-
munostaining was not affected.
Discussion
CWD is a fatal neurologic disease of free-ranging
mule deer and white-tailed deer in northcentral Colo-
rado, southern Wyoming, western Nebraska, and a
small region of Saskachewan, Canada. CWD is a
member of the prion family of disorders, a novel group
of transmissible spongiform encephalopathies (TSEs)
characterized by accumulation of a protease-resistant
isoform (PrPres) of a normal host sialoglycoprotein
(PrPsen) in the brain of affected individuals. The TSEs
of domestic livestock include ovine scrapie, bovine
spongiform encephalopathy, and a CWD of game-
raised elk in the USA, Canada, and Korea and of free-
ranging elk in the mule deer CWD-endemic area.
The TSEs of ruminant herbivores are characterized
by spongiform lesions in the central nervous system
of clinically affected animals. The lesions are associ-
ated with PrPres detectable by IHC of formalin-fixed
tissue. PrPres accumulation precedes the appearance of
microscopic lesions in the brain of sheep8 and elk12
and is therefore a reliable marker for TSE in sheep or
elk during the preclinical stage of the disease. PrPres
can also be detected in tonsil of sheep with TSE
months or years before accumulation in the brain can
be detected.15 Early lymphoid accumulation of PrPres
is seen in experimentally infected mule deer13 and nat-
urally exposed mule deer in the CWD-endemic area.
Therefore, IHC assays on tonsil and other lymphoid
tissues10 of sheep and mule deer are useful preclinical
antemortem and postmortem diagnostic tests for ovine
scrapie. In this study, an assay for detection of PrPres
in brain and tonsil tissue from mule deer with naturally
occurring CWD was evaluated. A sensitive, specific
MAb-based IHC assay for identifying preclinically in-
fected deer will be useful in large-scale surveillance
studies and in experimental studies on pathogenesis
and transmission of CWD in mule deer and related
species.
In this study, the use of MAb F99/97.6.1 in an IHC
assay of formalin-fixed tissues was examined. MAb-
based assays may be more useful than those based on
rabbit or goat antisera, which are limited in quantity,
specificity, and often in titer. However, use of an MAb
with specificity restricted to a single epitope might
lead to false-negative findings in outbred species if the
antibody binding site is variable. The deduced amino
acid sequence of the epitope for MAb F99/97.6.1 is
conserved in sheep and cattle, and no variation in the
DNA encoding this site has been found in a survey of
more than 100 mule deer and white-tailed deer (data
not shown).
PrPres has the same primary amino acid sequence as
the ubiquitously expressed cellular isoform PrPsen. No
commercially available antibody distinguishes be-
tween the cellular isoform and the disease-specific iso-
form in IHC. Specificity for the disease-associated
form of the protein in IHC is achieved by treatment
of the tissue with formalin and formic acid, which re-
duces or eliminates the availability of the epitope on
PrPsen 1 followed by antigen retrieval with formic acid6
and hydrated autoclaving.5 The formalin and formic
acid sensitivity of epitopes on PrP isoforms varies with
species and with tissue type. Formic acid pretreatment
of formalin-fixed lymphoid tissue from sheep before
processing and embedment (in addition to treatment of
hydrated sections on slides before autoclaving) is re-
quired for specificity in an IHC assay using a cocktail
of MAbs F89/160.1.5 and F99/97.6.1, although pre-
treatment of brain before the processing stage does not
appear necessary. Likewise, immunostaining with
MAb F89/160.1.5 in this study was highly specific in
deer brain but resulted in false-positive reactions in
some samples of deer tonsil, probably because of de-
tection of the epitope on PrPsen.
Immunostaining with MAb F99/97.6.1 using the
protocol described here is a sensitive and specific test
for detecting PrPres in palatine tonsil and brain of mule
deer with CWD. This technique detected PrPres in brain
of all 100 CWD-positive mule deer in the study and
in tonsil of 99 of these deer. One animal showed no
detectable tonsillar PrPres in spite of abundant neural
deposition. Accumulation of PrPres in the central ner-
vous system but not the lymphoid tissues has been
noted in a small subset of sheep with ovine scra-
pie.4,10,15 Tissue tropism may be affected by dose, route
of exposure, agent strain differences, host genetics, or
the level of PrPsen expression in host lymphoid and
neural tissues. Postmortem sampling of paired samples
of brain and tonsil will provide the most sensitive in-
dicator of CWD in mule deer. If tonsil is the only
tissue sampled in antemortem studies, the low per-
centage of mule deer with no detectable lymphoid
PrPres immunostaining should not affect large-scale
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prevalence studies but may be a consideration in
smaller experimental trials.
Freezing and autolysis did not seem to play a role
in affecting the IHC results for these tissues. The value
of this technique is especially evident in large surveys
of cervids for CWD. In the last 6–7 years, extensive
surveys for the presence of CWD have been done in
free-ranging deer and in free-ranging and captive elk.9
Often, several postmortem days have elapsed by the
time the samples are processed, making the diagnosis
of CWD difficult or impossible with HE staining. The
use of IHC has greatly facilitated the ability to diag-
nose CWD in these autolytic field specimens.
MAb99-IHC as described here is a specific and sen-
sitive assay for diagnosing CWD in mule deer by de-
tecting PrPres in palatine tonsil and brain. The tech-
nique will also have value in transmission and patho-
genesis studies on this emerging TSE.
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